title: Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk.
abstract: Natural killer (NK) cells play a critical role in antitumor immunity, their activation being regulated through NK cell receptors. Although the endogenous ligands for these receptors are largely unknown, viral ligands have been identified. We investigated the ability of an activating NK receptor ligand derived from the mumps virus, haemagglutinin-neuraminidase (HN) to enhance NK activation against tumor cells. HN-expressing B16.OVA tumor cells induced stronger activation of NK cells compared with B16.OVA cells and also promoted dendritic cell (DC) activation toward a DC1 phenotype, in vitro. Moreover, incubation of DCs, NK cells and HN-expressing B16-OVA cells further enhanced NK cell activation through the NK-DC crosstalk, in a cell-to-cell contact- and IL-12-dependent fashion. Immunization of mice with HN-expressing B16-OVA cells resulted in > 85% survival rate after subsequent challenge with parental B16 or B16.OVA tumor cells. Tumor rejection was dependent on both NK and CD8+ T cells but not on CD4+ T cells, demonstrating induction of an effective adaptive immune response through innate immune cell activation. Our data indicate the potential of using robust NK cell activation, which through the NK-DC crosstalk stimulates effective antitumor responses, providing an alternate vaccine strategy.
authors.affiliation: Cancer Sciences Unit; Faculty of Medicine; University of Southampton; Southampton, UK.
authors.forename: Fay
authors.initials: F
authors.lastname: Chinnery
authors.forename: Catherine A
authors.initials: CA
authors.lastname: King
authors.forename: Tim
authors.initials: T
authors.lastname: Elliott
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Bateman
authors.forename: Edward
authors.initials: E
authors.lastname: James